NOVO-B.CO vs. U
NOVO-B.CO (Novo Nordisk A/S) and U (Unity Software Inc.) are both stocks. NOVO-B.CO operates in Biotechnology (Healthcare), while U operates in Software - Application (Technology). Over the past 5 years, NOVO-B.CO returned 19.11%/yr vs -20.90%/yr for U. At a 0.06 correlation, their price movements are largely independent.
Performance
NOVO-B.CO vs. U - Performance Comparison
Loading charts...
Different Trading Currencies
NOVO-B.CO is traded in DKK, while U is traded in USD. To make them comparable, the U values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -14.51% return, which is significantly higher than U's -33.60% return.
NOVO-B.CO
- 1D
- -1.18%
- 1M
- -7.41%
- YTD
- -14.51%
- 6M
- -7.00%
- 1Y
- -42.63%
- 3Y*
- 2.27%
- 5Y*
- 19.11%
- 10Y*
- 15.87%
U
- 1D
- -1.43%
- 1M
- 4.45%
- YTD
- -33.60%
- 6M
- -40.75%
- 1Y
- 13.39%
- 3Y*
- -9.51%
- 5Y*
- -20.90%
- 10Y*
- —
NOVO-B.CO vs. U - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | -14.51% | -46.40% | -9.59% | 205.34% | 31.49% | 79.08% | -1.95% |
U Unity Software Inc. | -33.60% | 73.55% | -41.39% | 39.08% | -78.76% | 0.00% | 98.33% |
Correlation
The correlation between NOVO-B.CO and U is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Sep 18, 2020 | 0.06 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOVO-B.CO vs. U — Risk / Return Rank
NOVO-B.CO
U
NOVO-B.CO vs. U - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Unity Software Inc. (U). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NOVO-B.CO | U | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.97 | ||
| Sortino ratioReturn per unit of downside risk | -1.71 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.11 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 0.20 | -0.99 |
| Martin ratioReturn relative to average drawdown | -1.16 | 0.41 | -1.57 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NOVO-B.CO | U | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.79 | 0.18 | -0.97 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | -0.28 | +0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.78 | -0.20 | +0.98 |
Drawdowns
NOVO-B.CO vs. U - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -76.75%, smaller than the maximum U drawdown of -92.76%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and U.
Loading charts...
Drawdown Indicators
| NOVO-B.CO | U | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.75% | -92.76% | +16.01% |
Max Drawdown (1Y)Largest decline over 1 year | -54.94% | -65.83% | +10.89% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -70.50% | -6.25% |
Max Drawdown (5Y)Largest decline over 5 years | -76.75% | -92.76% | +16.01% |
Max Drawdown (10Y)Largest decline over 10 years | -76.75% | — | — |
Current DrawdownCurrent decline from peak | -72.07% | -85.82% | +13.75% |
Average DrawdownAverage peak-to-trough decline | -11.25% | -68.58% | +57.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.82% | 32.78% | +4.04% |
Volatility
NOVO-B.CO vs. U - Volatility Comparison
The current volatility for Novo Nordisk A/S (NOVO-B.CO) is 10.59%, while Unity Software Inc. (U) has a volatility of 15.71%. This indicates that NOVO-B.CO experiences smaller price fluctuations and is considered to be less risky than U based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOVO-B.CO | U | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.59% | 15.71% | -5.12% |
Volatility (6M)Calculated over the trailing 6-month period | 39.29% | 60.20% | -20.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.59% | 74.32% | -19.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.54% | 76.18% | -17.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.06% | 75.59% | -30.53% |
Dividends
NOVO-B.CO vs. U - Dividend Comparison
NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%, while U has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | 4.35% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
U Unity Software Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NOVO-B.CO vs. U - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Unity Software Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NOVO-B.CO and U have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOVO-B.CO and U
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer